Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study-Reference-Cited by-同舟云学术

Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study

Published:2010-03-15 Issue:5 Volume:26 Page:1083-1089
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Fliser D.¹,Kleophas W.²,Dellanna F.²,Winkler R.E.³,Backs W.⁴,Kraatz U.⁵,Fassbinder W.⁶,Wizemann V.⁷,Strack G.⁸

Affiliation:

1. Department of Internal Medicine IV, Saarland University Medical Centre, Homburg/Saar, Germany

2. Dialysezentrum, Düsseldorf, Germany

3. Gemeinschaftspraxis für Innere Medizin, Nephrologie, Rostock, Germany

4. Dialysepraxis Barmbeck, Hamburg, Germany

5. KfH – Nierenzentrum, Demmin, Germany

6. KfH-Nierenzentrum, Fulda, Germany

7. Nephrologische Gemeinschaftspraxis, Germany

8. Gemeinschaftspraxis für Innere Medizin, Nephrologie, Bad König, Germany

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007991003666652

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone Decreases Erythropoietin Stimulating Agent Use in Men on Hemodialysis;Androgens: Clinical Research and Therapeutics;2020-10-01

2. Time spent on erythropoietin stimulating agents administration in hemodialysis centers in Panama: a time and motion study;Journal of Medical Economics;2019-04-12

3. Fixed dose of long-acting erythropoietic stimulating agents at higher frequency improves appetite, reduces inflammation and corrects anaemia in patients on haemodialysis;Clinical and Experimental Pharmacology and Physiology;2016-09-01

4. Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials;Advances in Therapy;2016-03-10

5. Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure;Expert Review of Hematology;2015-11-17